Related Experiment Video
Updated: Feb 26, 2026

Isolation of Adipose Tissue Immune Cells
Published on: May 22, 2013
Immunosenescence Induced by Plasma from Individuals with Obesity Caused Cell Signaling Dysfunction and Inflammation
Mariana Migliorini Parisi1,2, Lucas Kich Grun1,2, Patrícia Lavandoski1
1Laboratory of Molecular Biology and Bioinformatics, Department of Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Objective:
To evaluate the consequences of plasma from individuals with obesity on parameters associated with immunosenescence in unrelated healthy peripheral blood mononuclear cells (PBMC).
Methods:
Freshly isolated PBMC were incubated in media supplemented with 10% of plasma from individuals with obesity or control subjects for the first 4 hours of 24 to 120 hours of culture.
Results:
Plasma from individuals with obesity modulated the phenotype of healthy PBMC, leading to a higher rate of apoptosis, lower amounts of phospho-γH2AX and -p53, and mitochondrial dysfunction. After 120 hours, there was a higher secretion of inflammatory cytokines IL-1β and IL-8. CD8+ T lymphocytes presented decreased expression of CD28, which is associated with the immunosenescent phenotype. CD14+ macrophages showed increased expression of CD80 and CD206, suggesting a modulation in the activation of macrophages.
Conclusions:
These results demonstrate that chronic systemic inflammation observed in obesity induces dysfunctional features in PBMC that are consistent with premature immunosenescence.
More Related Videos
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
Obesity
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Psychoneuroimmunology: Diabetes and Cancer
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution